Media formats available:
Recommended
- ACC.24
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
Carolyn Lam, MD, PhD
Maria Luiza Caramori, MD, PhD
Ana Maria Cebrián-Cuenca, MD, PhD
Carolyn Lam, MD
- Tackling the risk of hyperkalemia through guideline-recommended heart failure therapyPrescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF
Aaron Wong, MD
- ESC Congress 2023Effect of SGLT2i on diuretic efficacy in acute heart failure